CClinicalTrials.gg
Status unknownNCT01686971Updated Sep 25, 2012

The Needs of Cancer Survivors

An observational study in Needs and Demands of Oncology Patients, Breast Cancer Patients. and Colon Cancer Patients., sponsored by Rambam Health Care Campus. Status unknown at 1 site in Israel. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2012-09-25.

Sponsored by Rambam Health Care Campus · Observational

The sponsor has not verified this record recently (last verified Sep 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 80 Years
Sex
All
01

Study summary

A questionaire for cancer patients without an active treatment in order to evaluate their needs and/or demands.

Read the detailed description

Cancer patients on finishing therapy will be interviewed by a registered nurse by a approved questionaire asking about his /her feeling needs and demands.

Efforts to help them will be trid

It is well known from studies that survivors have unmet medical and non-medical needs that are not met, this includes physical, emotional and practical issues. The purpose of this study is to study them and investigate the methods how to alleviate them.

All patients with breast and colon cancer that are refered to the Rambam Oncology center will be investigated.

02

Conditions studied

  • Needs and Demands of Oncology Patients
  • Breast Cancer Patients.
  • Colon Cancer Patients.

Browse trials for

03

In context

Colonic Neoplasms

1,432 studies on the registry are indexed under Colonic Neoplasms; 357 are open to participants now.

This study's planned enrollment of 150 is below the median of 280 across 349 observational studies indexed under Colonic Neoplasms.

Browse Colonic Neoplasms studies →

Lead sponsor

Rambam Health Care Campus is the lead sponsor of 456 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Oncology patients at the end of theier treatment. The patients will consist from 2 most common cancer diseases:Breast cancer and colon cancer.

Inclusion criteria

  • Patients diagnosed with two common cancers (breast, colon) that have completed the treatment (chemotherapy, radiotherapy)
  • Male and Female patients 18-80 years old.

Exclusion criteria

Exclusion Criteria:

  • Patients with active disease.
  • Recipients of care that matches the criteria of hospice care.
  • Patients with a diagnosis of dementia or other cognitive failure
  • Patients who do not speak Hebrew
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
150 participants (estimated)

Groups and cohorts

  • questionaire

    patients will receive a questionaire and speak to a nurse regarding their needs and/ or demands.

06

Study locations

1 site
  • Rambam MC
    Haifa, 31096, Israel
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 25, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01686971
Lead sponsor
Rambam Health Care Campus
Responsible party
Sponsor
First posted
Sep 18, 2012
Start date
Nov 2012
Primary completion
May 2013 (estimated)
Completion
Nov 2013 (estimated)
Last update
Sep 25, 2012

Study contacts

Eliezer Robinson, Proffesor
principal investigator · Rambam MC

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion